Complexa Inc., a company spun out of the Universty of Pittsburg, is planning for human trials of a new class of anti-inflammatory drugs to treat diabetes, kidney failure and other diseases. The company will be well placed to attract new capital following a report by Ernst & Young that has found that Pittsburgh technology companies continue to outpace national averages in the amount of venture dollars invested in regional companies.
The company’s research has been spurred from Dr. Bruce Freeman’s…
